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Ionizing radiation
How to use this issue...
This issue begins with a composite case study that describes realistic encounters with patients. The case study 
is followed by a pretest. (Answers to the Pretest questions are on pages 31-32.) The monograph ends with a 
posttest, which can be submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for 
continuing medical education (CME) credit or continuing education units (CEU). See page 35 for further 
instructions on how to receive these credits.
The objectives of this monograph on ionizing radiation are to help you
□  Explain why exposure to ionizing radiation is a health concern
□  Describe the health effects caused by exposure to ionizing radiation
□  Identify evaluation and treatment protocols for radiation-exposed patients










Treatment and Management................. 22
Standards and Regulations................... 26
Suggested Reading List........................ 28
Other Sources of Information................ 29
Pretest and Challenge Answers............ 31
Posttest and Credits.............................. 35
Appendices............................................39
This issue is prepared for the U.S. Department of Energy with the assistance of those who share a common 
concern for physician education, public health, and the environment, including the following organizations: 
American Academy of Clinical Toxicology, American Academy of Family Physicians, American Academy of 
Pediatrics, American College of Emergency Physicians, American College of Occupational and Environmental 
Medicine, American Medical Association, Association of State and Territorial Health Officials, Physicians for 
Social Responsibility, and the Society of Teachers of Family Medicine. Final responsibility for the contents and 
views expressed in this monograph resides with ATSDR.
Agency for Toxic Substances and Disease Registry 
Project Officers: Max Lum, EdD; Donna Orti, MS; and Patricia Poindexter, MPH 
Edited by Teresa Ramsey, MA 
Prepared by 
DeLima Associates, San Rafael, California, 
under Contract No. 205-90-0817
Case Study
Radiation contamination caused by a transportation accident
You are a physician on duty in the emergency department of a hospital in a community of approximately 40,000 
residents. At 7:45 A.M. you receive notification of a vehicular accident about 4 miles northeast of the city. A truck 
carrying radioactive material struck a guard rail and rolled 200 feet down an embankment. The truck, which came 
to rest at a point about 15 feet from the river bank, is on fire. The driver of the truck has minor burns on his hands 
and a deep laceration of the scalp; he is conscious but somewhat confused and incoherent. His assistant, a 
passenger in the truck, has second-degree burns on his hands and a simple fracture of his lower left leg.
A member of the highway patrol, who was first on scene and noticed the radioactivity placard on the truck, 
contacted a health physicist from the regional office of the Department of Energy. The health physicist found that 
the driver of the truck and his assistant are externally contaminated with the radioactive material, which is emitting 
beta and gamma radiation. The health physicist also detected radioactive contamination along the truck’s path as 
it rolled down the embankment. Three ruptured containers of radioactive material were found near the truck; it is 
believed that their contents may have entered the river. The community you serve relies on the river for drinking 
water, as well as for recreational activities.
State police have rerouted traffic and placed road blocks at all points within a 3-mile radius of the accident. 
However, a young boy whose family is vacationing on a houseboat about 20 yards from the site where the truck 
came to rest, is known to have approached the scene immediately after the accident occurred. The highway patrol 
is attempting to locate the boy.
iPretest
(a) Where could you obtain consultation on treatment and management o f persons contaminated 
with radioactivity?
(b) Describe appropriate initial management o f the driver and his assistant.
(c) Is the young boy who has not been located in danger? Explain.
Are the other occupants of the houseboat at risk as a result o f the accident?
(d) If the radioactive material entered the river and consisted of aqueous potassium iodide, what steps 
could be taken to protect the residents o f your community who rely on the river for drinking water? 
Would these steps differ if  the radioactive waste consisted o f cesium-137 in solution?
Answers to the Pretest can be found on pages 31-32.
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Introduction
□  Radiation is of two types: 
ionizing and nonionizing.
The nature of ionizing radiation 
is particulate (e.g., alpha or 
beta radiation) or wave-like 
(e.g., X or gamma radiation).
The nuclear reactor accidents at Three Mile Island in Pennsylvania 
in 1979 and at Chernobyl in the USSR in 1986 have increased the 
public’s concern about exposure to radiation. Awareness of the 
potential health effects of elevated levels of radon in homes has 
intensified that concern. The purpose of this document is to help 
clinicians answer patients’ questions about the early and long-term 
effects of radiation exposure, the risks of radiation in diagnostic and 
therapeutic medical procedures, and the potential dangers of radia­
tion to the fetus and future generations.
Events just before the turn of the century, which included Roentgen’s 
discovery of X rays and Becquerel’s recognition of natural radioac­
tivity, allowed us to understand how radiation is produced and how 
it interacts with matter. Radiation may be of two types, ionizing or 
nonionizing (Figure 1). Ionizing radiation is capable of physically 
disrupting neutral atoms by dislodging orbital electrons, thus forming 
an ion pairconsisting of the dislodged electron and the residual atom. 
Ion pairs are chemically reactive and may produce toxic agents in the 
cell (e.g., free radicals from water), which can interfere with normal 
life processes. Nonionizing radiation, on the other hand, does not 
dislodge orbital electrons or destroy the physical integrity of an 
impacted atom. The health effects of nonionizing radiation are not 
addressed in this document.











Gamma radiation X radiation
Adapted from: Leach-Marshall JM. Analysis of radiation detected from exposed process elements from the krypton-85 fine 
leak testing system, page 50. Semiconductor Safety Association Journal 1991; 5(2): 48-60.
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Ionizing Radiation
Ionizing radiation exists as either particles or electromagnetic waves. 
Particulate radiation (e.g., alpha particles, beta particles, neutrons, 
and protons) has finite mass and may or may not carry a charge. 
Electromagnetic radiation, on the other hand, has no mass or charge; 
it consists of electric and magnetic forces that move at the speed of 
light in consistent patterns of various wavelengths. The continuum of 
wavelengths constitutes the electromagnetic spectrum. The shorter 
wavelengths—gamma radiation and X radiation—have high ener­
gies, and like particulate radiation, are capable of ionizing matter. The 
longer wavelengths of the electromagnetic spectrum, which include 
radio waves; microwaves; and infrared, visible, and ultraviolet radia­
tion have relatively low energies and are nonionizing.
Not all forms of ionizing radiation have the same biologic effects. 
Generally speaking, for directly ionizing particles, the ion density 
along the path of low-energy radiation is greater than that along the 
path of high-energy radiation; low-energy radiation moves slower and 
has more time to interact. However, the total pathway of low-energy 
radiation is usually shorter, so the total number of interactions may well 
be less than with high-energy radiation. Similarly, the ion density 
toward the end of the radiation path is greater than at the beginning 
because the velocity of the radiation is less and the probability of 
interaction is greater. Alpha particles are capable of producing the 
highest specific ionization (i.e., greatest number of ion pairs per unit 
length of path), followed in order by beta particles and electrons. 
X radiation and gamma radiation interact with matter by transferring 
energy to electrons. (For more information, see Appendix I, Forms of 
Ionizing Radiation.)
The units that have evolved to measure ionizing radiation are the 
result of its many facets. Radiation units (Table 1) may characterize 
the (1) energy, (2) radioactive decay rate, (3) effect in air, (4) ability to 
be absorbed by matter, or (5) biologic effect. Units may be modified by 
prefixes such as m/7//' (indicating thousandths of the base unit), micro 
(millionths), pico (billionths), kilo (a thousand times), or mega (a million 
times).
The units used most commonly in this document are rad (radiation 
absorbed dose) and rem (roentgen equivalent in man or mammal). 
The rad describes the dose of radiation in terms of the amount of 
energy absorbed by a given mass, for example, of water or tissue. The 
absorption of 100 ergs of ionization energy in 1 gram of water has a 
value of 1 rad.
Use of the rem takes into account the biologic effectiveness of the 
various types of radiation. The rem is numerically equal to the rad 
multiplied by a Radiation Weighting Factor (formerly “quality factor”). 
The Radiation Weighting Factor (RWF) reflects differences in the 
amount of each type of radiation necessary to produce the same 
biologic effect. For beta, gamma, and X radiation, RWF is 1.0, making 
their effect on tissue equivalent. The RWF for alpha particles is 20, 
indicating its biologic effect is 20 times greater than the effect of beta, 




Kinetic energy of an electron as it moves 
through a potential difference of 1 volt.
Radioactivity emitted per unit of time
(1 Ci = 3.7 x 1010 disintegrations per second).
Amount of X and gamma radiation that causes 
ionization in air. One roentgen of exposure 
will produce about 2 billion ion pairs per cubic 
centimeter of air.
Dose resulting from one roentgen of ionizing 
radiation deposited in any medium, typically 
water or tissue. One rad results in the absorp­
tion of 100 ergs of ionizing radiation per gram 
of medium.
Dose of any form of ionizing radiation that 
produces the same biological effect as 
1 roentgen; 1 rem = 1 rad x Radiation 
Weighting Factor (RWF), where the value of 
RWF depends on the type of radiation as 
follows:
X radiation = 1.0 
gamma radiation = 1.0 
beta =1.0 
alpha = 20
neutrons = 5 to 20, depending on 
their energy
A new System Internationale (SI) nomenclature has been adopted, 
which is used by international, as well as many domestic, profes­
sional organizations and journals (Table 2).
Table 2. Equivalency of international units
Unit Symbol Equivalency
Gray Gy 1 Gy = 100 rad
Sievert Sv 1 Sv = 100 rem
Becquerel Bq 1 Bq = 2.7 x 10‘11 Ci (or
1.0 disintegration per
second)
Table 1. Units of radiation measurement
Characteristic Unit
Energy electron volt (eV)
(also ergs, joule)
Rate of radioactive decay curie (Ci)






(1) A health physicist from the state health department calculates that the young boy at the scene 
of the accident in the case study potentially received a maximum radiation dose o f 50 millirads 
(mrad). Express this dose in millirems (mrem) and Sieverts (Sv).
(2) What dose o f X radiation would produce the same biologic effect as 50 mrad o f gamma or beta 
radiation ? If the radioactive material in the case study had been an alpha-emitter instead o f a beta 
and gamma emitter, would the biologic effects be greater? Explain.
Exposure Pathways
Humans receive an average radiation dose of 300 to 450 mrems 
per year from both natural (about 82%) and man-made (about 
18%) sources. Natural radiation background (Figure 2) is from 
terrestrial sources and from high-energy particles emanating 
from stars (including our sun) and other bodies in outer space. 
Cosmic radiation consists mostly of protons (about 90%), with 
the remainder being alpha particles, neutrons, and electrons; 
only about 1/1000 of cosmic radiation penetrates to the earth’s 
surface.
Near sea level, cosmic radiation results in an average dose of 
ionizing radiation to U.S. residents of about 30 mrem/year. At 
higher elevations, such as in the Rocky Mountains, where there 
is less atmosphere to act as a shield, exposures due to cosmic 
radiation increase by a factor of about two. An even greater 
increase is experienced during high-altitude air travel; however, 
passengers of commercial flights are airborne at high altitudes 
for only a few hours at a time and do not receive significant 
exposures from this source.
Our environment includes 
continual irradiation from both 
cosmic and terrestrial 
sources; this natural radiation 
background is significantly 
affected by altitude and 
geology.
In addition to natural back­
ground, an individual's radia­
tion exposure can be increased 
by factors such as lifestyle 
(e.g., smoking), geography 
(e.g., location of residence) and 
health requirements (e.g., 




Figure 2. Sources of ionizing radiation exposure for the U.S. population 





11% MEDICAL X RAYS
4% NUCLEAR MEDICINE




Nuclear Fuel Cycle 0.1% 
Miscellaneous 0.1%
Adapted with permission from Health effects of exposure to low levels of ionizing radiation: BEIR V. Copyright 1988 
by the National Academy of Sciences. Courtesy of the National Academy Press, Washington, DC.
Terrestrial radiation comes from radioactive elements (radionuclides) 
that were present at the time the earth was formed, and that continue 
to decay, forming additional radionuclides in the process. Unusual soil 
composition has increased background radiation twenty-fivefold or 
more in a few areas in the world. Locations with high background due 
to naturally occurring radioactive elements in the soil, most of which 
are derived from the decay of uranium, include the Rocky Mountains 
(100 mrem/year); Kerala, India (1300 mrem/year); coastal regions of 
Brazil (500 mrem/year); granite rock areas of France (265 mrem/year); 
and the northern Nile Delta (350 mrem/year). In the United States, the 
lowest radiation dose rates are attributed to the sandy soils of the 
Atlantic and Gulf coastal plains.
One of the products formed during the decay of uranium is radon-222, 
an alpha-emitting radionuclide. Radon-222 contributes an average 
equivalent whole-body dose of about 200 mrem/year. Studies of 
uranium miners and other populations have indicated that inhalation 
of radon-222 increases the risk of lung cancer, especially in smokers. 
(See Case Studies in Environmental Medicine: Radon Toxicity.) 
Residents of homes built on abandoned uranium mine and mill 
tailings or near uranium mines, such as in the Southwest United 
States (e.g., Mesa County, Colorado) or in areas in Czechoslovakia, 
have increased internal radiation exposure due to inhalation of 
radon, as well as increased external radiation exposure due to 
uranium in the soil.
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Construction materials such as wood, granite, and brick bring 
terrestrial radioactive sources into closer proximity. The dose rate 
that is attributable to the naturally occurring radionuclides in wood 
frame buildings is typically less than 10 mrem/year; occupants of 
masonry structures receive a dose rate of about 13 mrem/year. The 
dose rate varies not only with the material, but also with ventilation, 
room size, room location within the structure, season of the year, and 
other factors.
Potassium is essential to health, and one of its isotopes, potassium- 
40, is radioactive. Potassium-40 makes its way into the body through 
foods (e.g., bananas) and through inhaled fossil-fuel combustion 
products (e.g., fly-ash particulates). Because potassium deposits in 
muscle tissue, potassium-40 is widely distributed throughout the 
body. We receive an annual internal dose to all organs of approxi­
mately 18 mrem from this radionuclide.
Radiation background from man-made sources includes fallout from 
aboveground atomic weapon detonations (about 1 mrem/year for 
U.S. inhabitants), nuclear fuel production and nuclear reactors (less 
than 1 mrem/year), medical devices (about 50 mrem/year), and 
various consumer products. Although the United States and the 
former USSR have stopped aboveground atomic detonations, the 
dose rate from atomic weapons testing will continue into the next 
century because of the long-lived isotopes formed during previous 
tests and the continued aboveground testing carried out by China 
and France.
As of 1990, 113 nuclear power plants were operating in the United 
States. In addition, 75 nuclear reactors were being used for training 
and research, while about 70 reactors were operating at U.S. Depart­
ment of Energy (DOE) facilities, and at least 100 were used to power 
military submarines, cruisers, and aircraft carriers. Supporting these 
reactors are mines, mills, processing plants, and storage sites for 
spent fuel, all of which are potential sources of radiation exposure. 
The current deposits of radioactive waste generated by production 
and use of atomic weapons and nuclear power reactors will remain 
a potential exposure hazard for 10,000 years or more.
Radiation exposure incurred for medical reasons can contribute the 
greatest dose from artificial sources. Worldwide, more than 1 billion 
medical diagnostic X-ray examinations, more than 300 million dental 
X-ray examinations, and about 4 million radiation therapy proce­
dures or courses of treatment are performed annually. In the United 
States, over half of the population is exposed to X radiation each 
year, and more than half of these are diagnostic procedures, 
including dental diagnosis. The rest experience X radiation during 
fluoroscopy, radiation therapy (Table 3), and nuclear medicine 
(Table 4).
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Table 3. Common diagnostic X-ray doses*
Examination Mean Mean Testes/ Embryo/
KVP MAS Ovaries Fetus
(mrem) (mrem)
Chest (PA) 80 12 <0.5 <0.5
Skull (lateral) 72 50 <0.5 <0.5
Abdomen (KUB, AP) 78 601 13.7/146 150
Retrograde pyelogram (AP) 77 91 17.2/161 170
Thoracic spine (AP) 75 82 <0.5/0.7 0.9
Cervical spine (AP) 69 48 <0.5 <0.5
Lumbosacral spine (AP) 77 112 13.2/145 150
Pelvis (AP) 100 30 83/79 133
Barium enema (AP) 120 20 68/132 140
* KVP = kilovolt peak; MAS = milliampere second; PA = posteroanterior view; AP = anteroposterior view; 
mrem = millirem; KUB = kidney, ureter, bladder.
Reprinted with permission from the August, 1987; volume 36, number 2, issue of American Family Physician, published by 
the American Academy of Family Physicians.
Table 4. Common radionuclides used in nuclear medicine




Lung Technetium-99t 3 10 Lung— 1000
Lung Xenon-133 gas 15 3 Lung— 150
Heart Thallium-201 chloride 1.5 360 Kidney—2200
Heart Technetium-9911 15 200 Blood—300
Liver Technetium-99§ 3 60 Liver— 1000
Bone Technetium-99** 20 200 Bone—450
Kidney Technetium-99tt 10 233 Kidney—500
* mCi = millicurie, mrem = millirem
t  Radionuclide delivered in microspheres of human serum albumin 
H Radionuclide incorporated in red blood cells 
§ Radionuclide delivered as sulfur colloid 
** Radionuclide incorporated in methylene diphosphonate 
t t  Radionuclide incorporated in diethylenetriaminepentaacetic acid (DTPA)
Adapted with permission from the August, 1987; volume 36, number 2, issue of American Family Physician, published by 
the American Academy of Family Physicians.
In contrast to environmental exposures, medical procedures usually 
restrict radiation to local areas. However, during the course of exposing 
only a small fraction of the body, relatively large doses may be 
delivered to the bone marrow, which, in comparison to other parts of 
the body, is very sensitive to radiation. Although the risks due to
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radiation exposure are small for patients undergoing medical treat­
ments, the cumulative risk to medical and dental personnel who are 
present is greater. In addition, staff who are not properly protected may 
receive whole-body, ratherthan localized, exposures. Procedures that 
can be used to protect health care personnel include limiting the time 
of exposure, maintaining an adequate distance between the X-ray 
beam and personnel, and providing adequate shielding.
A number of natural and artificially produced radioactive materials are 
used in consumer products. Of these, tobacco products probably 
represent the single greatest radiation hazard to smokers. Tobacco 
smoke contains polonium-210 and lead-210, alpha-emitting radon 
decay products. These radionuclides may be deposited and retained 
on the large, sticky leaves of tobacco plants or may derive from the 
uranium naturally present in the phosphate fertilizers used on the 
plants. When the tobacco in a cigarette is lit, the radioactive materials 
are volatilized and enter the lungs. The bronchial lining of the lungs of 
a person who smokes 1.5 packs of cigarettes per day may receive as 
much as 16,000 mrem/year (Table 5). The radiation from tobacco 
smoke may contribute to the carcinogenicity associated with active and 
passive cigarette smoking.
Although radiation values for dental porcelain and eyeglasses (Table 
5) are large, these sources are not a health hazard because the 
radiation they produce is distributed over a few millionths of an inch in 
comparatively insensitive tissues; the total contribution of dental porce­
lain and eyeglasses as an equivalent whole-body dose is less than 
5 mrem/year. (For more information, see Appendix II, Radionuclides of 
Potential Concern in the Environment.)
Table 5. Background radiation from consumer products
Product
Coal combustion (fly ash) 
Oil combustion (soot)
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superficial layers of tissue in 
contact with teeth 
cornea 
whole body
* Dose for cigarette smokers only; does not include doses experienced by those subjected to passive smoke, 
t  Due to the uranium present in glazed dental porcelain.
H Applies to eyeglasses tinted with uranium or thorium.
Adapted from: National Council on Radiation Protection and Measurements (NCRP). Radiation exposure of the U.S. population 




(3) List at least five potential sources of radiation unrelated to the workplace to which the truck 
driver in the case study may be exposed. Compare the annual dose from each o f these sources.
Who's at Risk
Workers in the nuclear 
energy and defense 
industries are at greatest 
risk of exposure to ionizing 
radiation.
Accidental releases of 
radiation can occur while 
producing, using, storing, or 
transporting radionuclides.
Long-term sequelae of 
acute high-level or low-level 
radiation (i.e., cancer and 
genetic effects) are difficult 
to assess for a number of 
reasons.
Important data about human effects from exposure to ionizing 
radiation come from survivors of the atomic bomb detonations in 
Hiroshima and Nagasaki. Additional evidence comes from inhabit­
ants of the Marshall Islands who experienced fallout from thermo­
nuclear testing on Bikini Atoll, radium dial painters, pioneer radiolo­
gists, and patients receiving radiation therapy (e.g., patients who 
were irradiated in the 1950s as treatment for ankylosing spondylitis). 
Effects of high-level exposure include acute radiation sickness and 
fatalities. The major long-term health risks of ionizing radiation are 
cancer, birth abnormalities (from in utero irradiation), infertility, and 
genetic abnormalities, which are discussed in Physiologic Effects, 
page 13.
Risk of radiation-induced cancer in human populations is difficult to 
calculate for four reasons: (1) the total number of known radiation- 
induced cases is too small and the doses too high to allow accurate 
extrapolation to low doses; (2) cancer from other causes is a 
prevalent disease (the incidence of cancer morbidity in the U.S. 
population is 30% to 35%), making incremental incidences due to 
radiation exposure difficult to detect; (3) radiation-induced can­
cer cannot be distinguished from cancer due to other causes 
(although investigators using new molecular biology techniques are 
attempting to make this distinction possible); and (4) the interval 
between radiation exposure and cancer appearance may be 
several decades.
Exposure to low-level ionizing radiation occurs mostly in the work­
place. Workers at risk are those involved in the following activities: 
operating nuclear power plants, other nuclear industrial facilities, or 
nuclear-powered naval vessels; purifying, enriching, and fabricat­
ing uranium for nuclear reactor fuel and for weapons production 
and use; and working at radionuclide storage sites. In addition,
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medical technicians; researchers; uranium miners and other under­
ground miners, cave guides, and spelunkers exposed to radon; indus­
trial radiographers; and geologists using radiologic devices to measure 
pressure in wells are at risk of radiation exposure.
Criticality accidents (due to uncontrolled nuclear fission) have occurred 
at Los Alamos, New Mexico, in 1958; Oak Ridge, Tennessee, in 1958; 
Hanford Works, Richland, Washington, in 1962; and Wood River 
Junction, Rhode Island, in 1964. In addition, two early experiments (in 
1945 and 1946) at the Los Alamos site resulted in uncontrolled nuclear 
fission. These accidents caused three early fatalities of workers closest 
to the nuclear reactions; the 22 other workers in the vicinity of the 
accidents were irradiated at doses less than 465 rem, and all survived 
for at least 5 years. The radiation from these accidents would have 
affected a larger area and a greater number of people if conditions 
during criticality had also resulted in the explosive release of large 
amounts of energy, which they did not.
The general public can be exposed to radiation through industrial or 
mining waste streams that contaminate air and drinking water. Re­
leases of iodine-131 to air and water occurred at nuclear power plants 
in Hanford, Washington, during the period from 1943 to the 1960s and 
at Three Mile Island in 1978. The release of radioactivity at the Three 
Mile Island nuclear power plant resulted in an average radiation dose 
to the surrounding population of about 8 mrem over a radius of 10 miles 
and about 2 mrem over a radius of 50 miles from the reactor. These 
doses are conservatively expected to cause an additional 0.7 cancer 
deaths in the population living within the affected 50-mile radius. (By 
contrast, the number of cancer deaths estimated to occur from all other 
causes during the lifetime of this population of 2 million persons is about 
390,000.)
Accidental releases of radioactive materials may also occur during 
transport of radionuclides or at sites storing them. Currently, low-level 
radioactive waste can be accepted at two commercial storage sites: 
Barnwell, South Carolina, and Hanford, Washington. The storage site 
at Beatty, Nevada, no longer accepts shipments of radioactive waste. 
No repository has yet been designated as a permanent storage site for 
high-level radioactive waste such as spent fuel from nuclear reactors.
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Biologic Fate
Depending on their physical 
state, radionuclides may 
enter the body by ingestion, 
inhalation, or by absorption 
through the skin. They may 
also enter the body through 
breaks in the skin.
Distribution, metabolism, 
and excretion depend on the 
radionuclide and its chemical 
form.
Radium and transuranic 
radionuclides may remain in 
the liver and bone for years.
Exposure to ionizing radiation can result from internal sources (i.e., 
radionuclides deposited within the body), external contamination 
(i.e., radionuclides deposited on the body surface), and irradiation by 
an external source. Internally deposited radionuclides frequently 
produce nonuniform radiation to proximate organs and tissues, 
depending on the radionuclide’s distribution and metabolic charac­
teristics. In many respects, internal contamination can be viewed as 
chronic exposure.
Radioactive substances can enter the body via inhalation, ingestion, 
skin absorption or through a contaminated wound. Inhalation is the 
most common route of internal contamination. Depending on particle 
size, aerosols may penetrate beyond the self-cleansing mucocilliary 
system of the central airways. For insoluble aerosols, such as oxides 
of plutonium and other transuranic elements (elements having an 
atomic number greater than uranium), the biologic fate usually 
includes transfer of the radionuclide by macrophages to regional 
lymph nodes and partial solubilization, with entry into the circulatory 
system. Heavy nuclides remain in the liver and bone for prolonged 
periods, typically years.
Hundreds of radioactive nuclides exist, but only a few are extensively 
used or produced and have the potential to cause significant internal 
contamination. The radionuclides in the environment of greatest 
potential concern are cesium-137, iodine-131, plutonium-239, radon- 
222, strontium-90, tritium, and uranium-238. A brief discussion of the 
biologic fates of each of these radionuclides can be found in 
Appendix II.
Cha([enge-Jr
Additional information for the case study: The radioactive material has been identified as an 
aqueous solution o f potassium iodide, which was prepared from iodide-131. The cargo was being 
delivered to a repository for storage o f low-level radioactive waste.
(4) Several hours after the accident occurred, a fireman who was first-on-scene is brought to the 
emergency room complaining o f mild chest pain. He asks you if  this pain could be caused by 
radioactivity in the smoke. Considering the biologic fate o f iodide-131, is this a likely cause o f the 




The immediate effect of exposure to high-level ionizing radiation is 
cytotoxicity, which results in changes in cellular function or direct cell 
death. Changes in cellular function may include delays in certain 
phases of the mitotic cycle (mitotic inhibition), disrupted cell growth, 
permeability changes, and changes in motility.
A suggested mechanism for radiation cytotoxicity involves the for­
mation of ions, which interact with water and create inhibitory toxic 
chemicals (e.g., hydrogen peroxide) and free radicals that destroy 
the integrity of proteins, DNA, or other cellular constituents. The 
body’s response to ionizing radiation depends on several factors, 
including the type and quality of radiation, dose, dose rate, and 
homogeneity of dose. If a cell receives a sublethal dose of radiation, 
cellular repair processes may be activated. Repair mechanisms are 
most likely responsible for the ability of the body to tolerate a higher 
total dose when exposure occurs over an extended period of time 
(i.e., at a low dose rate).
Cytotoxicity from radiation varies among cell types and tissues. In 
general, rapidly dividing cells that are poorly differentiated are most 
radiosensitive. For example, lymphocytes, primitive stem cells of the 
bone marrow, mucosal crypt cells of the gastrointestinal tract, 
spermatogonia, and granulosa cells of the ovary are particularly 
affected by radiation. Endothelial cells of the microcirculation and 
epithelial cells of many organs have an intermediate sensitivity. 
Muscle cells, neurons, erythrocytes, and polymorphonuclear granu­
locytes are relatively resistant to radiation. In most cases, maximum 
organ damage becomes evident as injured progenitor cells fail to 
replace the lost mature cells.
Cancer
The largest body of evidence in support of the ability of ionizing 
radiation to produce cancer derives from studies of the survivors of 
the atomic detonations during World War II. The increased rates of 
various cancers in those persons are consistent with the increased 
rates for comparable cancers in other irradiated populations. A 
radiation dose of 100 rem causes about a 5% increase in the risk for 
developing a fatal cancer. Risk of some cancers (e.g., female breast 
cancer and multiple myeloma) more than doubles with exposure 
doses greater than 100 rem. A reasonable estimate of additional 
cancer mortality risk from a one-time whole-body dose of 1 rem is
1 to 5 fatal cancers in 10,000 persons so exposed (0.01% to 0.05%). 
This risk is in addition to the cancer mortality risk in the general U.S. 
population of about 1950 fatal cases in 10,000 persons (19. 5%).
The first radiation-induced malignancy to appear in the atomic bomb 
survivors was leukemia. The latent period between radiation expo­
sure and clinical recognition of leukemia ranged from 2 to 15 years.
□  Rapidly dividing cells are the 
most sensitive to ionizing 
radiation.
□  Hematopoietic changes be­
come observable at exposure 
levels of about 25 to 100 rem. 
Changes in the function of 
most other cells or immediate 
cell death occurs at exposure 
levels greater than 100 rem.
□  DNA repair mechanisms likely 
influence the effects of 
radiation exposure that has 
occurred over an extended 
period of time.
□  Large doses of ionizing 
radiation will significantly 
increase the incidence of 
cancer in a population. 
However, at low doses, the 
incidence of radiation- 




□  The fetus, with its rapidly 
dividing cells, is especially 
radiosensitive.
The risk to the survivors of developing this disease varies with the 
type of leukemia and the age at the time of exposure. For example, the 
incidence of chronic lymphocytic leukemia (CLL) is not measurably 
affected by the radiation level or dose, whereas the incidence of all 
other types of leukemia has been reported to increase with dose, and 
the risk is greater to those who were exposed at a younger age.
In the Japanese survivors, increased incidences for solid cancers 
appeared considerably later than the excess of leukemia. Carcinoma 
of the thyroid was the first of the solid tumors noted. An increased 
incidence of multiple myeloma and cancers at the following sites was 
also found: breast (female), lung, stomach, esophagus, small intes­
tine, colon and rectum, brain and nervous system, ovary, uterus, 
urinary tract, and salivary glands. In populations irradiated occupation­
ally or primarily for medical reasons, an increased incidence of cancers 
at these sites has also been reported, as well as at other specific sites 
including liver [due to internally deposited radionuclides], skeleton, 
and skin. Current medical reagents and procedures in nuclear medi­
cine are designed to minimize residual radionuclides in the body and 
adverse side effects.
As with leukemia, the risks for solid tumors in the Japanese survivors 
are greater in persons who were younger at the time of exposure. The 
latency period for solid tumors due to radiation exposure is gener­
ally one or more decades. Interestingly, an increase in pancreatic 
cancer, the fourth leading type of fatal cancer in the United States, was 
not observed in atomic bomb survivors and has been observed 
inconsistently in other irradiated human populations (i.e., no clear 
relationship to dose or time after exposure could be identified).
Developmental Effects
Exposure of pregnant women to ionizing radiation has been studied 
in several populations including survivors of the atomic bomb detona­
tions in Japan. Preimplantation radiation exposure (i.e., within 2 weeks 
after conception) has not been found to produce anomalies in the 
fetus. If preimplantation damage occurs, it is likely that spontaneous 
abortion ensues. In women exposed during pregnancy, increased 
incidences of miscarriages, stillbirths, and neonatal deaths have been 
reported. Children exposed in utero have shown an excess of con­
genital defects.
In children born to survivors of the atomic bomb detonations, a 
pronounced association exists between gestational age at the time of 
exposure and the risk of neurodevelopmental effects. Exposure 
occurring during the first 7 weeks of gestation did not result in 
increased risks for mental retardation, reduced IQ, or seizure disor­
ders. Exposures greater than 50 rad during gestational weeks 8 to 15, 
when nerve development and migration are greatest, showed linear 
dose-effect relationships for each of the above three endpoints and for 
microcephaly. This gestational period (i.e., 8to 15 weeks) is recognized
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as the most sensitive for the development of fetal neurologic effects 
(see Case Studies in Environmental Medicine: Reproductive and 
Developmental Hazards). A no-effect threshold for adverse neuro- 
developmental effects during this gestational period could not be 
determined.
Exposures that occurred during 16 to 25 weeks of pregnancy also 
resulted in an increased risk of adverse neurodevelopmental effects, 
but to a lesser degree than during the period of peak sensitivity. 
Irradiation during the 16th to 25th week did not produce a linear 
relationship between dose and effect. In fact, a threshold for mental 
retardation appeared to exist. After 25 weeks of gestation, radiation 
exposures generally cause stunting of growth in the fetus, result­
ing in a newborn who has reduced physical size but remains 
normal in other ways.
Genetic Effects
In nonhuman forms of life, the developmental and genetic effects of 
ionizing radiation are well documented. Radiation exposure in these 
life forms results in congenital abnormalities and mutations that are 
transmitted to immediate and remote offspring. In experimental 
animals, the frequency of genetic effects due to radiation exposure 
generally increases as a linear-nonthreshold function of dose.
An epidemiologic study in Japan compared 38,000 children conceived 
after one or both parents were exposed to radiation from atomic 
detonations with 37,000 children whose parents were not exposed. 
No statistically significant differences were found in stillbirths, birth 
weight, infant mortality, or sex ratio. Among children of the exposed 
parents, there was also no effect seen on electrophoretic variants of 
28 proteins of blood plasma and erythrocytes. These results may be 
due to relevant factors that were not controlled in the study. Although 
this study was negative, it does not prove that humans are exempt 
from radiation-induced genetic effects.
The dose needed to double the mutation rate in humans has been 
calculated to be higher than 100 rem, which is twice the average 
gonadal dose received by the atomic bomb survivors. Although the 
children of the survivors exhibited no inherited chromosomal 
abnormalities, the survivors themselves showed a dose-dependent 
increase in chromosomal abnormalities in somatic cells (i.e., circulat­
ing blood lymphocytes), which has also been detected in other 
populations exposed to ionizing radiation.
Some studies involving women who have had medical X-ray expo­
sures suggest an association between maternal preconception expo­
sure to ionizing radiation and the incidence of Down syndrome, while 
others do not. Thus, the studies are inconclusive. A similar paternal 
radiation effect has not been noted. Children whose parents
Genetic effects due to ionizing 
radiation are well documented 
in animals and other non­
human forms of life.
Although inheritable defects 
have not been evident in 
atomic bomb survivors, no 
reason exists to assume that 





received preconception exposures of greaterthan 1 rem at Hiroshima 
and Nagasaki have not exhibited increased incidences of Down 
syndrome, leukemia, or non-Hodgkin’s lymphoma.
Cfiatienge
Additional information for the case study: The boy is located with friends several hours after the 
accident and taken to the emergency department o f the local hospital. He says he did not come 
in contact with the radioactive material.
(5) Is the boy a hazard to those with whom he has come in contact since the accident? 
Explain.





Approximately half of those receiving a radiation dose of 500 
rem will die within 30 days if untreated. Below 1000 rem, deaths 
are attributable to failure of the hematopoietic system. For 
doses between 1000 and 10,000 rem, death occurs due to 
ulceration and bleeding in the gastrointestinal tract. Doses 
above 10,000 rem immediately affect the cells of the nervous 
system. Depending on the exposure dose, these subsyndromes 
(i.e., hematopoietic, gastrointestinal, and neurovascular), which 
make up the acute radiation syndrome, may be discrete or 
overlapping (Table 6).
No immediate symptoms 
occur from acute doses of 
whoie-body radiation below 
about 100 rem.
The acute radiation syndrome 
consists of subsyndromes 
involving the hematopoietic, 
gastrointestinal, and 
neurovascular systems.













No detectable clinical effects; small increase in risk of delayed cancer and genetic effects
Temporary reductions in lymphocytes and neutrophils; sickness not common; long-term 
effects possible
Minimal symptoms; nausea/vomiting/diarrhea/fatigue in a few hours; reduction in lymphocytes 
and neutrophils, with delayed recovery; possible bone growth retardation in children
Nausea and vomiting on first day; following latent period of up to 2 weeks, symptoms (loss of 
appetite and general malaise) appear but are not severe; hematopoietic subsyndrome; 
recovery likely in about 3 months unless complicated by previous poor health
Nausea, vomiting, and diarrhea in first few hours, followed by latent period as long as 1 week 
with no definite symptoms; loss of appetite, general malaise, and fever during second week, 
followed by hemorrhage, purpura, inflammation of mouth and throat, diarrhea, and intestine 
destruction in third week; some deaths in 2-6 weeks; possible eventual death to 50% of 
those exposed
Vomiting in 100% of victims within first few hours; diarrhea, hemorrhage, and fever toward end 
of first week; rapid emaciation; almost certain death
Vomiting within 5-30 minutes; 100% incidence of death within 2-4 days
Vomiting immediately; 100% incidence of death within a few hours to 2 days
In men yields temporary sterility 
In women yields permanent sterility
*rem = rad equivalent in man or mammal
Adapted from: Goldman M. Ionizing radiation and its risks. In: Occupational disease—new vistas for medicine. West J 
Med 1982;137:540-7.
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Acute radiation illness begins with a prodromal period manifesting 
within hours or a few days. Prodromal symptoms include anorexia, 
nausea, vomiting, and diarrhea. A latent period of 5 to 7 days then 
occurs during which the patient appears to have recovered. Within
2 weeks after exposure, the patient will manifest illness that requires 
aggressive therapy; this critical period may last up to 4 weeks. 
Generally, the higher the absorbed dose, the shorter the latent period 
and the more rapid the onset and severity of illness during the critical 
period.
At levels above 100 rem whole-body dose, radiation-sensitive stem 
cells in the bone marrow and lymphoid tissues are destroyed or 
mitotically impaired. The more radio-resistant mature elements nor­
mally circulating in the blood cannot be replaced promptly, and fatal 
hemorrhage can result from platelet loss. Infection from decreased 
production of granulocytes and other cells can also occur. Recovery 
has been reported after exposure to 300 to 600 rem when intensive 
supportive care was provided. Erythrocyte production is also de­
creased, but in the absence of bleeding, anemia develops only slowly 
and in modest severity because erythrocytes have a long life span.
Acute radiation doses exceeding 600 rem to the abdomen or whole 
body usually result in significant damage and reproductive impairment 
of rapidly proliferating crypt stem cells, thus producing the gastrointes­
tinal tract subsyndrome. The existing mucosa is shed, preventing 
normal absorption and causing the gut to leak electrolytes and blood. 
The denuded mucosa becomes a portal of entry for intestinal bacteria; 
severe diarrhea, shock, and sepsis occur. Although medical therapy 
may delay death from these causes, the patient usually succumbs.
Acute doses of more than 3000 rem cause damage to capillaries, 
resulting in a more immediate neurovascular subsyndrome. Within 
1 hour after exposure, neurologic symptoms of confusion, prostration, 
and loss of balance develop. Diarrhea, respiratory distress, intractable 
hypotension, and central nervous system (CNS) collapse rapidly 
ensue. Massive damage to the microcirculation probably is respon­
sible for the cerebral edema that causes brain damage. The initial 
hypotension may be due to release of histamine by the granulated 
mast cells. At this radiation dose, medical efforts are futile, and death 
occurs within 48 hours after exposure.
Ionizing Radiation
Local Radiation Injury
In a radiation accident, high local exposures may complicate whole- 
body exposures. Since 1945, about 300 radiation accidents have 
occurred in the United States, the majority of which have involved 
industrial devices containing cobalt-60 or iridium-192. Injury to the 
skin depends on the type of radiation, as well as the strength of the 
source and duration of the contact. For example, beta radiation 
typically produces a shallow injury, whereas gamma radiation pen­
etrates more deeply. Both cobalt-60 and iridium-192 are gamma 
emitters and can produce contact doses that result in immediate and 
severe third-degree burns. Third-degree contact burns are gener­
ally painless and actual skin damage may be worse than is immedi­
ately apparent. Most local injuries involve the hand; other common 
sites are the thighs and buttocks when radioactive sources are 
carried in pants’ pockets. The acute radiation syndrome may also be 
present in patients who have severe local contact injury.
The intensity of radiation from a source decreases as the distance 
from the source increases, in accordance with the “inverse square” 
rule. For example, a dose of 1024 rads at 1 meter from a source is 
reduced to 256 rads at 2 meters and 64 rads at 4 meters. If the 
immediate signs and symptoms after a local radiation exposure 
include erythema of skin and severe pain, the local absorbed dose 
is probably in excess of 1000 rads. Evidence of transepithelial injury 
and dry desquamation may follow. At doses above about 2000 rads, 
blistering and a wet radiodermatitis may ensue. Later, tissue necro­
sis due to secondary vascular impairment may occur. These injuries 
are similar to thermal burns in appearance. In radiation cases, 
erythema may increase during the first week after exposure and fade 




Instruments used to measure radiation levels in the environment are 
generally of two types: area survey meters and personnel dosim­
eters. If either dosimetry is available, contact a health physicist for 
interpretation. These radiation experts are employed at local or state 
departments of health, universities, and the Radiation Emergency 
Assistance Center/Training Site (REAC/TS) at Oak Ridge Institute for 
Science and Education (see Other Sources o f Information, page 29).
Internal Indicators
If whole-body radiation has occurred, several hematologic param­
eters can be used to predict biologic effects, as well as to estimate 
physical dose. The earliest indicator is a fall in the lymphocyte 
count, which may reach its nadir within 48 hours (Figure 3). At doses
□  Contact with a radioactive 
source can result in 
burns that are worse than 
is immediately apparent.
□  Most local radiation injuries 
involve the hands.
□  An accurate assessment of 
radiation dose is a useful, 
though not essential, 
confirmatory aid to clinical 
judgment in treating severely 
affected patients.
□  Lymphocytes are a biologic 
marker for radiation 
exposure.
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up to 300 rad, the rate of fall In circulating lymphocytes is related 
directly to dose. At doses greater than 300 rad, profound 
lymphocytopenia occurs, and lymphocyte count becomes unreli­
able for dose estimation.
Figure 3. Typical hematologic response* to a whole- 
body radiation dose of 450 rads
DAYS
* Lymphocyte, neutrophil, and platelet values should be multiplied by 1000. 
Hemoglobin values are in grams per deciliter.
Adapted from: Goldman M. Ionizing' radiation and its risks. In: Occupational 
disease—new vistas for medicine. West J Med 1982;137:540-7.
Unlike lymphocytes, granulocytes (represented by neutrophils in Figure 
3) are not directly lysed by radiation and provide another indication of 
dose. At whole-body doses of 200 to 500 rads, a brief rise in the peripheral 
granulocytic count typically occurs in the first few days after exposure. 
The rise, which is a nonspecific stress response, is followed by a 
progressive fall, an abortive rise or plateau, and another fall, the true 
nadir of which is reached within 30 days after exposure. Doses greater 
than 500 rads cause increasingly earlie r and more severe 
granulocytopenia. The severity of thrombocytopenia (see platelets in 
Figure 3) is also an indicator of dose.
A useful and sensitive biomarker for dose estimation in acute whole- 
body radiation exposures, as well as to predict the long-term health risks 
in large populations exposed to low levels of radiation, is the chromo­
some aberration assay. Radiation induces several nonspecific but 
characteristic chromosomal abnormalities, particularly dicentric chro­
mosomes. By scoring the frequency of these abnormalities in lympho­
cytes in the peripheral blood or bone marrow and comparing the 
frequency to aberrations produced by irradiating peripheral blood in
Ionizing Radiatior
vitro, a relatively accurate estimation of radiation dose can be made. 
Chromosomal aberrations are visible within hours after radiation 
exposure, and the optimum time to perform the assay is within the first 
few weeks after exposure. Details of sample preparation and the 
names of laboratories able to perform cytogenetic assays for radiation 
exposure can be obtained from REAC/TS (telephone: [615J-576-3131 
[day]; [615] 481-1000 [24-hour hotline]).
Indicators of internally deposited radionuclides will depend on the 
biologic fate and the biologic half-life of the radioactive substance. 
If the metabolic pathway and biologic and physical half-lives are 
known, an estimate of dose to the target organ can be made by 
bioassay. Methods for measuring the amount of radioactivity in the 
body include urinalysis, fecal analysis, whole body scans, and 
thyroid scans for exposure to radioactive iodine.
Cytogenetic assays may also be used to detect damage from internally 
deposited radionuclides. However, these data are not useful in esti­
mating dose to the target organ because internal radionuclides are 
seldom distributed uniformly within the body. This uneven distribution 
can affect the radiation received by the circulating lymphocytes and 
even their survival.
(7) About 36 hours after arriving at the emergency department, the driver in the case study and 
his assistant experience nausea and vomiting. What is the prognosis for these patients?
(8) In the emergency room you have an opportunity to examine the young boy. What history or other 
information will help you determine his prognosis?
(9) One month later, the boy's parents ask you to perform a test that will prove the boy was exposed 





An important consideration in 
decontamination is to prevent 
the spread of radioactive 
materials.
The psychologic effects of 
actual or potential radiation 
exposure are often overlooked.
If radioactive materials are present in a workplace, it is important to 
have decontamination materials available and a written plan for their 
utilization. Radiation detection equipment is used to identify a worker 
contaminated with radioactive liquids or solids (e.g., dusts), as well 
as the body area that is contaminated.
The first step in decontamination is removal of contaminated clothing, 
then careful washing of the areas around eyes, nose, and mouth with 
a washcloth. Showering should be avoided when external contami­
nation is localized because showering can spread radionuclides to 
clean areas. Mild soap and water are frequently all that is needed to 
emulsify and remove contamination. Gentle brushing or use of a 
mildly abrasive soap will help dislodge contamination physically held 
by skin protein. Harsh abrasives should be used cautiously because 
they may open a path through the keratinized layer of the skin and 
allow internal contamination. Addition of a chelating agent to the 
wash water may help by binding the radionuclide in a complex. 
Contaminated wash water must be collected and disposed of prop­
erly. Instructions for disposal can be obtained from REAC/TS (tele­
phone: [615J-576-3131 [day]; [615] 481-1000 [24-hour hotline]).
Radiation monitoring of the cleaned, dried skin should be done 
between washings. If repeated washings do not totally remove 
contamination, the material is probably fixed in skin, which will 
normally be shed; a frequently changed bandage over the area will 
prevent spread of contamination via the sloughed skin. In stubborn 
cases where contamination is localized in the thick horny layers, such 
as palms and soles of feet, sticky tape or a high-speed abrasive wheel 
can be used. However, if these techniques are not used properly, they 
can lead to skin cuts or increased percutaneous absorption. It may be 
necessary to remove contaminated hair by using clippers or an 
electric razor. All potentially contaminated material, including hair, 
debrided tissue, and, if internal contamination has occurred, vomitus 
and excretion products, must be collected in plastic bags for proper 
disposal.
If the contaminated worker is physically traumatized, the emergency 
department plan for management of radiation-accident casualties 
should be executed. Lifesaving medical care takes precedence over 
decontamination procedures. After emergency care has been admin­
istered, gross decontamination should be conducted on site. Further 
decontamination can occur at the medical facility. The patient should 
be wrapped in blankets to prevent the spread of contamination during 
transport. If the medical facility is not prepared for radiation decon­
tamination and does not have an appropriate decontamination room, 
the patient should be decontaminated outside or away from areas
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where normal activities occur. Care must be taken to prevent the 
spread of radioactivity within the facility.
The general public perceives the risk of death or injury from 
radiation as greater than do scientists. Dealing with the fear and 
mental stress caused by an accident is a significant part of emer­
gency management. Techniques for combatting this anxiety in­
clude educating the public before an emergency occurs, efficiently 
disseminating factual information using a single credible source 
during the emergency, and presenting evidence that a plan to 
manage the emergency is in place and working.
Acute Radiation Syndrome
Patients who have received acute total body radiation of 500 rads 
or more will develop severe pancytopenia and will require aggressive 
supportive measures. Patients developing aplastic anemia are at risk 
for systemic bacterial, fungal, and viral infections; infections and 
bleeding are the major causes of morbidity and mortality. Clinicians 
are encouraged to consult a hematologist, radiation oncologist, health 
physicist, or other radiation specialist knowledgeable about acute 
radiation illness and its treatment. Some referral sources are given in 
Other Sources o f Information, page 29. A general treatment scheme 
for acute radiation injury is presented in Figure 4.
Local Radiation Injury
Radiation exposures that produce only erythema (300-1000 rad) can 
be treated as first-degree burns. Burns that result in desquamation 
(1000-2000 rad) are transepidermal and are similar to second- 
degree burns. Large surface-area burns may require systemic 
hydration. Skin grafting may be useful, but success depends on the 
depth of radiation penetration and the vascular status of the under­
lying tissues. Third-degree burns are produced by doses greater 
than 3000 rad. Third-degree burns heal by scarring; as a result, 
contraction and loss of function may occur, particularly if extremities 
are involved. Extensive plastic surgery may be required to prevent 
or limit loss of function. Amputation may be necessary.
Internal Contamination
Two strategies exist for treatment of a patient who is internally 
contaminated (i.e., cases where radioactive material is incorpo­
rated in the body via inhalation, ingestion, or through skin or 
wounds). The first strategy depends on reducing both the internal 
absorption and deposition of radioactive material (“blocking”); the 
second strategy depends on enhancing the elimination and excre­
tion of the radioactive material (“decorporation”).
□  Bleeding and infections, 
which are the primary causes 
of morbidity and mortality in 
patients acutely exposed to 
radiation, should be promptly 
treated by specialists.
□  Treatment depends on the 
area of the burn and the 
depth of radiation penetration.
□  Generally, treatment
strategies involve reducing 




Figure 4. Treatment scheme for patients receiving an acute high-dose radiation 
exposure
* W hole-body exposures greater than 4 Gy may require bone marrow transplantation or administration of colony-stimulating 
factors or other hematopoietic growth factors that stimulate proliferation of hematopoietic stem cells. However, few data exist 
to support firm recommendations about the use of these treatments for radiation victims.
Adapted from: Browne D, Weiss JF, MacVitlie TJ, Pillai MV. Treatment of radiation injuries. New York: Plenum Press, 1990.
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In radiation accidents, the identity of the radionuclide contaminant 
and its chemical and physical state must ultimately be determined. 
Radionuclides present at a workplace are usually known, and 
shipping documents and load manifests detail the hazardous 
contaminantsat transportation accidents. Sometimes it will not be 
clear whether internal contamination has occurred. Samples col­
lected during external decontamination will provide clues about 
possible internal contamination. Skin wipes, nasal swabs, urine, 
and feces should be collected for analysis at a laboratory capable 
of detecting and identifying radionuclides. Local and whole-body 
counting can be done at specialized facilities. As mentioned above, 
gentle mechanical cleansing of wounds and skin and the areas 
around mouth and nose will prevent further ingestion and absorp­
tion of radioactive materials.
Treatment of a patient who 
is internally contaminated is 
specific to the contaminating 
radionuclide and chemical 
form.
Chelation with diethylenetriaminepentaacetic acid (DTPA) acceler­
ates the urinary excretion of some transuranic metals (e.g., pluto­
nium, californium, americium, and curium) and some rare earth ions 
(e.g., cerium, yttrium, lanthanum, promethium, and scandium). DTPA 
is an investigational drug available from REAC/TS (see Other Sources 
of Information, page 29). DTPA can be administered intravenously or 
as an inhaled aerosol according to treatment protocols established 
by investigators at REAC/TS. In rare cases of massive pulmonary 
deposition of very hazardous aerosolized radionuclides, lung lavage 
may be of value. Appendix III is a treatment summary for selected 
elements.
Challenge
(10) How will you manage and treat the truck driver and his assistant in the case study? Assuming 
the young boy has experienced no immediate effects from the irradiation, what follow-up is 
appropriate for him?
Additional information for the case study: An hour after the accident, the concentration of 
radioactivity at the point where the material entered the river was measured at 20 picoCuries per lite r 
(pCi/L) o f river water. The town switched to an alternate source o f drinking water. Two weeks later, 
the state public health department declared the river water safe, and the town resumed using the 
river as its source o f drinking water.
(11) You continue to receive calls from your patients, expressing fear and concern about exposure 
to radioactivity. One of these patients insists that a rash that developed on his arm yesterday is 
caused by showering with “radioactive water.” A patient who is pregnant fears that her unborn 




During the period 1900 to 1930, standards for radiation protection 
were informal and set quite high (approximately 60 R/year). They 
reflected concern for acute effects of exposure. When concerns over 
the long-term effects of radiation exposure began to develop (1930 
to 1950), protection standards were formalized. The recommenda­
tion in 1934 of the U.S. Advisory Committee on X-Ray and Radium 
Protection (now the National Council on Radiation Protection and 
Measurements [NCRP]) was to restrict whole-body exposures to less 
than 0.1 R/day. From 1950 to 1960, attention centered on genetic 
effects of radiation exposure, and recommendations were proposed 
to limit exposure to the equivalent of 5 rem/year, which applied to 
both the general public and workers. Because any amount of 
radiation exposure poses some risk, all standards now employ a 
philosophy that radiation exposures should be limited to levels that 
are as low as reasonably achievable (ALARA) and consistent with the 
benefits of radiation to society.
Regulatory agencies in the United States that are involved in 
radiation control include the Nuclear Regulatory Commission, De­
partment of Transportation, Food and Drug Administration, Occupa­
tional Safety and Health Administration, and the General Accounting 
Office. EPA has also established a standard for drinking water of 
5 pCi/L, which applies to radioactivity from radium-226 and radium- 
228 combined. A new drinking water standard of 20 pCi/L each for 
radium-226 and radium-228 has been proposed.
Many states and cities also have regulations concerning the use of 
and protection from radiation. NCRP, established in 1964 to advise 
Congress on issues related to radiation, and the International 
Commission on Radiological Protection (ICRP) recommend the 
standards in Table 7.
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Table 7. Summary of recommendations for ionizing radiation
Dose Limits for Workers*
ICRP, 1991t NCRP, 199311
Based on stochastic effects 
(e.g., cancer and genetic damage)
5 rem (50 mSv) annual 
effective dose limit 
and
10 rem (100 mSv) as 5-year 
cumulative effective dose 
limit
5 rem (50 mSv) annual 
effective dose limit 
and
1 rem (10 mSv) times age in 
years cumulative effective 
dose limit
Based on nonstochastic effects 
(e.g., lens cataracts and fertility 
impairment)
Dose Limits for the Public*
Based on stochastic effects
Based on nonstochastic effects
15 rem (150 mSv) equivalent 
dose limit to lens of eye 
and
50 rem (500 mSv) annual 
equivalent dose limit to skin, 
hands, and feet
ICRP, 1991
0.1 rem (1 mSv) annual 
effective dose limit, and, if 
needed, higher values provided 
that the annual average over 
5 years does not exceed 0.1 rem
1.5 rem (15 mSv) annual 
equivalent to lens of eye 
and
5 rem (50 mSv) annual equivalent 
dose limit to skin, hands, and feet
15 rem (150 mSv) annual 
equivalent dose limit to 
lens of eye 
and
50 rem (500 mSv) annual 
equivalent dose limit to 
skin, hands, and feet
NCRP, 1993
0.1 rem (1 mSv) annual 
effective dose limit for 
continuous exposure 
and
0.5 rem (5 mSv) annual 
dose limit for infrequent 
exposure
5 rem (50 mSv) annual 
equivalent dose limit to lens 
of eye, skin, and extremities
Embryo-fetus 0.2 rem (2 mSv) equivalent dose to 0.05 rem (0.5 mSv) equiva-
the woman’s abdomen once lent dose limit in a month
pregnancy has been declared once pregnancy is known
* The dose limits for both workers and the public exclude medical and natural background exposures. Note that the dose limits for the public 
are lower, in general, than those for workers. Workers, by virtue of the ability to work, tend to be a healthier population than the public, which 
includes susceptible populations, the elderly, and children,
t  International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection, 
ICRP Publication 60, Annals of the ICRP 21. Elmsford, New York: Pergamon Press, 1991.
1) National Council on Radiation Protection and Measurements (NCRP). Limitation of exposure to ionizing radiation. Bethesda, Maryland: 
NCRP, 1993. NCRP Report No. 116.
§ Stochastic effects are those effects for which the probability of occurrence, rather than the magnitude of the effect, is proportional to dose. 
Not all irradiated persons show such effects; however, the probability that they will can be described by a dose-response curve that extends 
to zero with no threshold. Nonstochastic effects are proportional in severity to the magnitude of the absorbed dose; they probably have 
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Other Sources of Information
More information on the adverse effects of ionizing radiation and the treatment and management of radiation- 
exposed persons can be obtained from ATSDR, your state and local health departments, and university medical 
centers. For clinical consultation and assistance, physicians and other health care providers are urged to contact
Radiation Emergency Assistance Center/Training Site (REAC/TS)
Telephone: (6l5)-576-3l3l (day); (615) 481-1000 (24-hour hotline) 
c/o Oak Ridge Institute for Science and Education, P.O. Box 117,
Oak Ridge, Tennessee, 37831-0117.
Information and assistance may also be obtained from the Nuclear Regulatory Commission (202) 492-7000 and 
CHEMTREC ([800] 424-9300; 24-hour hotline) or from the offices listed below.
The United States Department of Energy (DOE) regional coordinating offices should be notified for radiological 
assistance as soon as possible. At the request of a patient or the attending physician, a DOE radiologic assistance 
team physician may give advice regarding hospitalization and further definitive treatment. The physician may also 
make available special DOE medical facilities for the diagnosis and treatment of radiation injury. DOE’s 
geographical areas of responsibility are listed below. Through this single contact, the resources of thirteen federal 
agencies will be made available.
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Department of Energy Regional Offices
Region 1 (Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New 
York, Pennsylvania, Rhode Island, and Vermont)
Brookhaven Area Office Upton, Long Island
(516)345-2200 New York, NY 11973
Region 2 (Arkansas, Kentucky, Louisiana, Mississippi, Missouri, Puerto Rico, Tennessee, Virginia, Virgin 
Islands, and West Virginia)
Oak Ridge Operations Office PO Box E
(615) 576-6833 or (615) 525-7885 Oak Ridge, TN 37831
Region 3 (Alabama, Canal Zone, Florida, Georgia, North Carolina, and South Carolina)
Savannah River Operations Office PO Box A
(803) 824-6331, ext. 3333 Aiken, SC 29802
Region 4 (Arizona, Kansas, New Mexico, Oklahoma, and Texas)
Albuquerque Operations Office PO Box 5400
(505)844-4667 Albuquerque, NM 87115
Region 5 (Illinois, Indiana, Iowa, Michigan, Minnesota, Nebraska, North Dakota, Ohio, South Dakota, and 
Wisconsin)
Chicago Operations Office 9800 S Cass Avenue
(312) 972-5731 or (312) 972-4800 Argonne, IL 60439
Region 6 (Colorado, Idaho, Montana, Utah, and Wyoming)
Idaho Operations Office PO Box 2108
(208)526-1515 Idaho Falls, ID 83401
Region 7 (California, Hawaii, and Nevada)
San Francisco Operations Office 333 Broadway
(510)273-4237 Oakland, CA 94612
Region 8 (Alaska, Oregon, and Washington)
Richland Operations Office PO Box 550
(509) 842-7381 Richland, WA 99352
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Answers to Pretest and Challenge Questions
Pretest questions are on page 1. Challenge questions begin on page 5.
Pretest
(a) Consultation for treatment of persons exposed to radiation may be obtained from REAC/TS at (615) 576- 
3131 (day) or (615) 481-1000 (24-hour hotline) or from other sources listed on page 29.
(b) Ideally, decontamination should be performed immediately at the site of the accident. Attending personnel 
must be properly protected to prevent secondary contamination. After emergency care for life-threatening 
trauma has been administered, the patients’ contaminated clothing should be removed and double-bagged. 
The patients’ skin and hair should be flushed with water, and the contaminated water should be caught in a 
child’s play pool or other device for later disposal. A mild soap may be used to remove oily or adherent material. 
Monitoring the clean, dried skin with a beta-gamma counter between flushings will indicate the effectiveness 
of the decontamination procedure.
If the accident occurs in inclement weather or at a site where washing facilities are unavailable or if the patient 
is in need of immediate medical care, decontamination may have to be delayed. In that case, care must be 
taken to prevent the spread of contamination during transport by wrapping the patient in blankets. If the hospital 
or other medical facility is not prepared to handle a patient who is externally contaminated with radioactivity, 
a temporary decontamination station can be set up at the medical care facility. It should be located outside, 
but if that is not feasible, it should be far removed from normal activity and other patient care areas. If 
decontamination is performed indoors, ventilation should be suspended so that no radioactivity escapes the 
room. Butcher paper taped to the floor and other surfaces is an effective barrier. All potentially contaminated 
material, including debrided tissue, must be collected in plastic bags for proper disposal. Attending personnel 
must be properly attired with disposable jumpsuits, gloves, or other protective equipment to avoid contamina­
tion through contact.
(c) The potential health consequences will depend on the boy’s interaction with the radioactive material. For 
example, it is not known whether the boy contacted the material and subsequently ingested radioactive 
material through hand-to-mouth activity, which would result in an internal contamination hazard. An external 
radiation hazard could exist if the boy contacted the material and is carrying radionuclides on his skin. Finally, 
the boy may have only approached the source, but may have been close enough to be exposed to beta and 
gamma radiation.
Assuming no contact occurred and the boy's proximity to the source were known, a radioactivity counter could 
provide dosimetric information that would aid in estimating his exposure. Maximum potential dose can also 
be calculated based on the characteristics of the source and the presumed location of the boy. The intensity 
of radiation decreases as the distance from the source increases, in accordance with the “inverse square” 
rule.
It is unlikely that the occupants of the houseboat would be affected by beta radiation, which has a relatively 
short range and can usually be stopped by a few feet of air. Gamma radiation has greater penetration than 
beta radiation; therefore, gamma radiation could have reached the houseboat about 20 yards from the source. 
However, shielding by the houseboat or other structures could reduce the radiation. A gamma counter might 
be used to obtain direct dosimetric information inside the houseboat.
(d) In this case, it is unlikely that any steps will be required to protect the members of the community who rely on 
the river for drinking water; however, a public health official will make that determination. Iodide-131 has a 
radiation half-life of 8 days. In just 32 days (4 half-lives) the amount of radioactivity will be one-sixteenth of what 
it was originally. Dilution by the river will also reduce the concentration of radioactivity.
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Should the radioactivity level be of concern, an alternate source of water can be supplied to the community 
during the time required for the radioactive material to decay to a level that is considered to be safe by a health 
physicist. The antidote for radioactive iodide is early administration (within about 2 hours of ingestion of 
radioactive iodine) of SSKI (supersaturated potassium iodide [Kl] solution) or iodide tablets. Stable iodide 
blocks absorption of iodide-131 in the thyroid. Oral administration of stable iodide is an effective and relatively 
inexpensive means to protect exposed residents of a community.
Cesium-137 has a 30-year radiologic half-life. It would take 120 years for the radioactivity from this source to 
decay to one-sixteenth of its original value. The water could remain unusable for a prolonged period depending 
on the concentration of cesium-137 and the characteristics of the river (e.g., volume and flow rate).
Cesium is distributed uniformly throughout the body and is rapidly eliminated by the kidneys. The experimental 
antidote for cesium is oral administration of ferric cyanoferrate (II). Commonly referred to as Prussian blue, this 
antidote binds the cesium ions that are enterically cycled and prevents their reabsorption from the gastrointes­
tinal tract. The effectiveness of the antidote depends on the length of treatment and how soon after exposure 
it is started. However, Prussian blue is not approved by the Food and Drug Administration for general use or 
as an antidote for radioactive cesium. A radiation specialist at REAC/TS should be consulted before the antidote 
is administered.
Challenge
(1) The RWF for beta or gamma radiation is one; therefore, a dose of 50 mrads of beta or gamma radiation is 
equivalent to 50 mrem or 0.05 rem. One Sieved equals 100 rem; therefore, 0.05 rem equals 0.0005 (5 x 10‘4) Sv.
(2) The RWF for X radiation is also one; therefore, a dose of 50 mrads of X radiation would produce the same 
biologic effect as 50 mrads of gamma or beta radiation.
Iodide-131 is not an alpha-emitter; however, if the radioactive material was emitting alpha particles and the 
material was ingested, the biologic effectiveness would be greater. The RWF for alpha particles is 20, which 
indicates a given dose of alpha radiation is twenty times more biologically effective than the same dose of beta 
or gamma radiation.
(3) Potential sources of radiation for the truck driver, as well as the general public, are as follows:
• Cosmic radiation and terrestrial radiation each produce an average dose rate of 30 mrem/year. Radon
exposure provides an additional dose of about 200 mrem/year.
• Potassium-40 naturally present in human tissue contributes an average dose rate of about 65 mrem/year.
• Building and construction materials contribute variable dose rates. Occupants of wood frame buildings
typically receive less than 10 mrem/year; occupants of masonry structures receive about 13 mrem/year.
• Atmospheric fallout provides an exposure dose rate of about 5 mrem/year.
• Consumer products, including tobacco, contribute a dose rate of less than 5 mrem/year when expressed as
whole-body exposure.
• Medical diagnostic and therapeutic radiation is variable and generally applied locally; the average dose rate
due to medical procedures is estimated to be 100 mrem/year.
(4) It is not likely that the radioactivity is the direct cause of the chest pain. If the iodide-131 vaporized and was 
inhaled, it would be absorbed from the lungs into the bloodstream and concentrated in the thyroid. However, 




(5) If the boy had no physical contact with the radioactive material and was only irradiated by the gamma and beta 
energy, he is not a radiation hazard to others. Had the boy contacted the waste and radioactive material was 
transferred to his skin or clothing, then he would be a hazard because the residue would continue to emit 
radiation and irradiate those nearby, or he could secondarily contaminate others through contact.
(6) All three of these persons are at increased risk of cancer, and the risk increases in proportion to the dose of 
radiation received. If the boy did not contact the radioactive material, he presumably received less radiation 
than the driver and his assistant, and therefore, would be at much less risk. A small proportion of persons 
exposed to radiation will develop cancer as a result; if exposed persons do develop cancer, it may never be 
certain whether the cancer was the result of radiation exposure or other causes. (A carcinoma induced by 
radiation is histologically indistinguishable from other carcinomas).
(7) Acute radiation syndrome is characterized by nausea and vomiting, which begins within 1 to 4 hours after 
exposure and may last as long as 48 hours, with the extent of symptoms related to the severity of exposure. 
The onset of vomiting for these patients is delayed, occurring about 36 hours after exposure; therefore, it is 
unlikely that these symptoms are directly due to radiation exposure. The cause must be sought elsewhere 
(e.g., anxiety). If the onset of nausea and vomiting was as late as 4 hours after exposure, the hematopoietic 
subsyndrome would likely ensue, and illness due to bleeding and infection could develop. In either case, with 
appropriate supportive care, the driver and his assistant should recover.
(8) Pertinent clinical history includes proximity to the source and duration of the exposure. Whether gastrointes­
tinal symptoms (nausea, vomiting, and diarrhea) have occurred is important because the time of onset of these 
symptoms can be inversely correlated with the severity of exposure. A complete blood count, including a 
lymphocyte count, can also help to estimate the severity of exposure; these tests should be repeated several 
times during the first few days after exposure.
(9) A useful and sensitive biomarker for radiation exposure in general is the chromosome aberration assay. 
Radiation induces several characteristic but nonspecific chromosomal abnormalities, particularly dicentric 
chromosomes, in peripheral blood lymphocytes. The optimum time to perform the assay is within hours to a 
few weeks after exposure. Only a few laboratories are prepared to perform and interpret this radiation 
cytogenetic assay; call REAC/TS at (6i5)-576-3i3i (day) or (615) 481-1000 (24-hour hotline) for further 
information.
(10) Assuming the truck driver and his assistant experienced no internal contamination, treatment is supportive 
and symptomatic. See page 24 for a treatment scheme that is based on the degree of irradiation.
During the next week, the boy’s lymphocyte count should be periodically checked; no other immediate follow- 
up is required. An ongoing medical surveillance program is unwarranted unless the clinical evidence 
contradicts the health physicist’s original estimate of maximum radiation exposure indicated in Challenge 
question 1. A whole-body dose of 50 mrads is similar to doses received in some medical diagnostic 
procedures.
(11) Fear is a natural reaction when people feel they may have been exposed to radiation. Reassurance is needed 
to alleviate the emotional and psychologic stresses that are caused when an accident involving radioactivity 
occurs. (See Ricks et al., 1991, in Suggested Reading List, page 29, for a discussion of the psychologic 
aspects of radiation exposure.)
You could point out that the levels of radioactivity initially found in the river soon after the accident were low 
(i.e., 20 pCi/L). Depending on the dynamics of the river, the radioactivity level is likely to be even lower now. 
The proposed drinking water standard for iodine-131 is 108 pCi/L.
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To further reassure these patients, you could suggest that they have their water tested for radioactivity. You 
or the health physicist could also calculate the potential maximum amount of radiation exposure and compare 
this to information in the literature (e.g., Table 6, page 17). No immediate clinical symptoms have been 
associated with the amount of radiation these patients were likely to have received by ingesting or contacting 




Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding continuing medical education (CME) credits and continuing education units 
(CEU) is a posttest score of 70% or better.
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (IACET) to sponsor continuing education units for other health 
professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in Category 1 of the Physician's Recognition Award of the American Medical Association and 0.1 hour of 
CEU for other health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for 
1 prescribed hour by the American Academy of Family Physicians (term of approval: beginning January 1992). For 
specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for 1 hour per issue of ACEP Category 1 credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Health Nurses (AAOHN). This independent study offering has 
been approved for 1.4 contact hours (term of approval beginning July 19,1996) by AAOHN, which is accredited 
as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission 
on Accreditation. For current approval status, contact AAOHN at 404-262-1162.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per 3 case studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEU), complete the Posttest on page 36 in the manner shown in 
the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?




After you have finished the Posttest, please record your answers on page 37 and complete the evaluation on the 
lower half of that page. Fold, staple, and mail that page to Continuing Education Coordinator, Agency for Toxic 
Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, NE, Atlanta, GA 30333. 
Your confidential test score will be returned with an indication of where the correct answers can be found in the 
text. Validation of earned CME credit and CEU will also be forwarded to participants, and their names, if requested, 




Circle all correct responses and record your answers on page 37.
1. Potential sources of radiation exposure include
a. isotopes inside the body
b. nuclear reactors
c. rocks and soil
d. automobile repair shops
e. medical radiation therapy facilities
2. Whole-body radiation exposures of 10 rem
a. double the risk of cancer.
b. produce small head size in most exposed fetuses.
c. cause erythema of the skin.
d. depress lymphocyte count within 48 hours.
e. cause no immediate clinical symptoms.
3. Patients irradiated by an external source of ionizing radiation
a. may be at risk for the acute radiation subsyndromes.
b. will require decontamination.
c. are a danger to emergency department personnel.
d. should have serial CBCs performed.
e. should be asked about nausea, vomiting, and diarrhea.
4. The hematopoietic radiation subsyndrome
a. may accompany the gastrointestinal subsyndrome.
b. is always lethal.
c. significantly depletes circulating red blood cells in 30 days.
d. has little effect on platelet levels.
e. causes a rapid drop in the lymphocyte count.
5. Local radiation burns
a. can be caused by beta radiation.
b. can be caused by alpha radiation.
c. can be caused by gamma radiation.
d. may require skin grafting.
e. begin with an immediate burning sensation.
6. Which of the following statement(s) is (are) true?
a. No treatment is available for patients who have inhaled plutonium-239.
b. Ingested iodide-131 can be treated with SSKI.
c. Persons who have been exposed to a cesium radiologic source may be treated with DTPA.
d. Persons who have ingested strontium-90 may be treated with barium sulfate.
e. Persons who have inhaled tritium may be treated with a saline infusion and furosemide.
7. Early external decontamination of a radiation accident victim
a. takes precedence over medical care.
b. includes removing the patient’s clothing.
c. must be carried out at a hospital.
d. should include careful cleaning of face and wounds.
e. ideally is continued until no radioactivity remains on skin.
8. Whole body acute radiation exposures greater than 1000 rem
a. produce nausea and vomiting that begins 48 hours after exposure.
b. cause only temporary reductions in lymphocytes and neutrophils.
c. double the dominant inheritable mutations in humans.
d. can cause death in less than 60 days.
e. are necessarily uniform in nature.
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CASE STUDIES IN ENVIRONMENTAL MEDICINE: IONIZING RADIATION
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 36 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education, E 3 3 , 1 600  Clifton Road, N E , 
Atlanta, GA 3 0 3 3 3 .
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by circling the appropriate number.
NEITHER
STRONGLY AGREE NOR STRONGLY
DISAGREE DISAGREE DISAGREE AGREE AGREE
1. As a result of completing this monograph, I will be able to:
Explain why ionizing radiation is a health concern. 1 2 3 4 5
Describe the health effects caused by exposure to
ionizing radiation. 1 2 3 4 5
Identify evaluation and treatment protocols for persons
exposed to ionizing radiation. 1 2 3 4 5
List sources of information on ionizing radiation. 1 2 3 4 5
The monograph addressed the objectives printed on the
inside front cover. 1 2 3 4 5
I am more likely to ask patients questions regarding possible
environmental exposures as a result of reading this issue. 1 2 3 4 5
Independent study was an effective teaching method for
the content. 1 2 3 4 5
How much time (in minutes) was required to read this monograph
and complete the posttest? 40 60 80 100 120
Comments:.
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Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Please send me the following Case Studies in Environmental Medicine:
□ Arsenic □  Exposure History a Radiation
□ Asbestos □  Gasoline a Radon
a Benzene □  Jet Fuel □ Reproductive and
a Beryllium □  Lead Developmental Haz
a Cadmium □  Mercury a Skin Lesions
a Carbon Tetrachloride □  Methanol a Stoddard Solvent
□ Chlordane □  Methylene Chloride a T etrachloroethylene
a Cholinesterase Inhibitors □  Nitrates/Nitrites a 1,1,1-Trichloroethane
a Chromium □  Pentachlorophenol a Trichloroethylene
a Cyanide □ Polyaromatic Hydrocarbons (PAHs) a Toluene
□ Dioxins □ Polychlorinated Biphenyls (PCBs) □ Vinyl Chloride
□ Ethylene/Propylene Glycols
staple or tape ML0993
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Appendix I 
Forms of Ionizing Radiation
Alpha particles, which are charged helium nuclei (i.e., 2 protons and 2 neutrons with an electrical charge of +2), 
have energies in the range of 4 to 8 million electron volts (MeV). Because of their mass and charge, alpha 
particles travel only a few centimeters in air and can be stopped by a piece of paper or intact skin. However, they 
cause intense ionization when they interact with matter and can result in significant local damage if emitted in 
body tissues by radionuclides incorporated through inhalation, ingestion, or through an open wound. Alpha 
particles are formed typically during the radioactive decay of radium-226 and transuranic elements such as 
plutonium and americium.
Beta particles originate in the disintegrating nucleus of radioactive elements (radionuclides). A beta particle is 
an electron that may be charged positively (positron) or negatively (negatron); it has a mass that is about 1/7500 
of an alpha particle. Beta particles are emitted from the nuclei of radionuclides at velocities approaching the 
speed of light and have peak energies ranging from about 0.010 to 4 MeV. They can travel several feet in air, but 
are typically stopped by a thin sheet of aluminum or 1 to 2 centimeters of plastic or paper. Effects of a beta-emitting 
radionuclide that is deposited in the body depend on whether the emitter is excreted or stored in tissue. Beta 
emitters commonly used in research include tritium, carbon-14, and iodine-131. Conversion and Auger electrons 
originate in the outer structure of the atom. They are monoenergetic with energies ranging from less than 0.001 
to 1 MeV and interact with matter in the same way as beta particles. An example of a radionuclide that emits such 
electrons is iodine-125.
Neutrons are emitted from the atomic nuclei of heavy elements when the elements are bombarded by high-speed 
particles. A neutron has a mass approximately equal to a proton (i.e., 1 atomic mass unit [amu]), but has no 
electrical charge. Neutrons do not interact with the orbital electrons of atoms as do most otherforms of radiation. 
Instead, neutrons interact with atomic nuclei. The disruption of the atomic nucleus may cause alpha, beta, or 
gamma radiation to be emitted. In addition, nuclear contact with either fast or slow (thermal) neutrons can cause 
acceleration of the target atom, resulting in dense ionizations along its path. Neutron radiation is produced in 
devices such as particle accelerators (high-energy neutrons) and nuclear reactors (low-energy neutrons). 
Neutrons can interact with water in the body; the proton making up the nucleus of a hydrogen atom in a molecule 
of water and nitrogen nuclei are the neutron's major targets in living tissue.
Gamma radiation is high-energy electromagnetic waves spontaneously emitted by the nucleus of radioactive 
atoms. Unlike the emission of alpha or beta radiation, the emission of gamma radiation results in a nucleus whose 
physical integrity is unaffected and whose energy state is more stable. X radiation differs from gamma radiation 
only in origin. X rays do not come from the nucleus; they are emitted when electron transitions occur in the atom's 
orbital shells. Both X and gamma radiations are highly penetrating and can be detected even after passing 
through several inches of steel. The energies of gamma and X rays are in the range of thousands of electron volts 
(keV) to MeV. In contrast to the dense ionization caused by particulate (e.g., alpha or neutron) radiation as it 
penetrates matter, gamma and X radiation create sparse ion pairs separated by relatively large distances. Alpha 
radiation generates 20,000 to 50,000 ion pairs/centimeter; beta, 50 to 500; and gamma, 5 to 8. Table 8 summarizes 
the characteristics of the various types of ionizing radiation.
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A few centimeters of 
lead; many inches of 
steel
X 0 0 Diagnostic and A few centimeters of
therapeutic medicine lead; many inches of
steel
* Familiar examples of originating source.




Radionuclides in the Environment of Potential Concern
Cesium-137
Cesium is an alkali metal that has 21 radioactive isotopes. The isotope most likely to be encountered is cesium-137 
because it is an important fission fragment produced during fissioning of either uranium or plutonium fuels. It is 
long-lived (radiation half-life of 30 years) and is found in the environment as a result of worldwide fallout associated 
with atmospheric weapons tests. It is used in industry as a sealed gamma source for measuring the thickness 
of materials and in medicine as a sealed source for therapy and as a tracer substance.
Cesium and potassium have similar chemical and biologic behavior, including distribution and metabolism in the 
body. Because of its water solubility, cesium is distributed almost uniformly throughout body fluids and is rapidly 
eliminated by the kidneys. The biologic half-life of cesium-137 ranges from 68 to 165 days; about 10% of the amount 
ingested is excreted within the first 2 days. The biologic half-life is much shorter in children, ranging from 12 days 
in infants to 57 days in older children, and somewhat shorter in women (up to 111 days reported).
Iodine-131
Radioactive iodines (especially iodine-131, -132, and -129) are important fission products from nuclear weapons 
tests and nuclear reactors. They are volatile substances and were an early concern in the accident at Three Mile 
Island in 1979. Once released to the atmosphere, radioactive iodine may return via precipitation to land used for 
pasture, thereby contaminating vegetation and, ultimately, the food and milk supply. Fallout from atmospheric 
nuclear weapons testing exposed residents of the Marshall Islands to radioactive iodine by ingestion, as well as 
external radiation. Iodine-131, which has a radiation half-life of 8.05 days, emits several medium-energy beta 
particles and mostly low-energy gamma rays. Because of the selective uptake of iodine by the thyroid, iodine- 
131 is used for medical examination and treatment of some thyroid conditions.
If iodine-131 is administered in the form of sodium iodide, it will distribute throughout the body. As the blood passes 
through the thyroid, about 20% of plasma iodide is removed per passage; in normal patients, 0.5% to 6.8% of the 
iodide in the circulating pool is removed per hour. About 30% of injected radioactivity may accumulate in the 
thyroid, where the iodine is rapidly bound to protein. It is released from the thyroid only slowly. Beta and gamma 
radiation from absorbed iodine-131 bound to circulating protein contributes to irradiation of the blood and bone 
marrow. Iodine also concentrates in the salivary glands and gastric mucosa. Excretion of iodine is almost entirely 
via urine.
The effective biologic half-life (radiation half-life combined with biologic half-life) of iodine-131 in humans is 
7.6 days. In infants, about 90% of the total beta energy from resident iodine-131 is absorbed by the thyroid gland, 
and in adults, about 95% of the total beta energy is absorbed. An increased frequency of nodules and cancers 
have been reported in persons exposed to radioactive iodine, and some patients treated for hyperthyroidism have 
developed hypothyroidism up to 17 years later.
Exposures to radioactive iodine usually result from inhalation, but ingestion and absorption through the skin also 
occur. In cases of environmental contamination with radioactive iodine (e.g., after a nuclear reactor accident), the 
clinician may be asked about the safety of drinking milk. In general, iodine-131 has an effective half-life on 
vegetation of about 5 days. An infant who drinks 1 liter of milk per day containing 1 microcurie per liter 
(jo.Ci/L) will receive a total cumulative dose to the thyroid of about 16 rem. The maximum permissible organ burden 
for continuous exposure to iodine-131 is a thyroid dose of 15 rem per year. Emergency reference levels 
(0.25 ja.Ci/L as a peak level in milk and 1.5 |xCi per square meter on pasture) should trigger protective actions, which
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include changing the cow forage, withholding milk from consumption, and diverting contaminated milk from direct 
use to milk products such as cheese, condensed milk, or powdered milk. Preparation time for these milk products 
would allow the iodine-131, with its relatively short half-life, to decay significantly, and the amount of emitted 
radiation would be of little consequence.
Plutonium-239
Plutonium is a man-made element. It is readily fissionable by neutrons and is used as fuel in nuclear power reactors 
and as a “trigger” device in explosive nuclear weapons. Reactor-grade plutonium is about 70% plutonium-239, and 
weapons-grade plutonium, about 93% plutonium-239. Plutonium-239 emits two high-energy alpha particles and 
has a radiation half-life of 24,390 years.
The most common route of entry to the body of plutonium-239 is through inhalation, usually of plutonium oxide 
(Pu02). As with all inhaled particulates, the particle size of the oxide will determine its deposition and location within 
the respiratory system. Small-diameter particles of Pu02 will remain in the lower respiratory tract and lungs for an 
average of 2 years, emitting very intense alpha radiation that can destroy small local masses of lung tissue and 
may result in lung cancer. Of the amount of PuC>2 inhaled, 15% reaches the thoracic lymph nodes (10% of this 
amount is retained permanently), 5% is found in the blood, and the remainder either stays in the respiratory tract 
or reaches the mouth and is swallowed. Workers may also be exposed to plutonium-239 through puncture wounds 
that occur via contaminated metal splinters or glass chips formed while processing the metal. Very little ingested 
Pu02 (about 0.003%) is absorbed through the gastrointestinal tract.
Plutonium in the blood is eventually equally distributed between liver and bone; a small amount settles in the 
abdominal lymph nodes, and an even smaller amount settles in the gonads. Retention half-time of plutonium-239 
in the whole body has been estimated to be 200 years in man, and the half-times in skeleton and liver are estimated 
to be 100 years and 40 years, respectively. Excretion is via the kidneys.
Nuclear weapons testing programs have placed more than 5000 kilograms of plutonium (representing 320 kCi) into 
the stratosphere, mostly as insoluble particles of oxide. In addition, 1 kg of plutonium-238 (17 kCi) that had been 
used as fuel for a power pack vaporized into the atmosphere from burn-up of a U.S. satellite. These releases have 
resulted in worldwide deposition. Plutonium-239 accumulation is uneven; areas having greater rainfall generally 
experience greater fallout. Increased amounts of radioactive plutonium have been found in soil near nuclear 
weapons testing, processing, and storage facilities. Wind action can resuspend the contaminated soil, carrying 
radioactive particles away from the site and increasing the hazard to nearby residents.
Radon-222
Radon results from the radioactive decay of radium, a ubiquitous element in rock and soil derived from the decay 
of uranium. Radon gas is odorless, colorless, tasteless, and cannot be detected, except by empirical measure­
ment. It seeps from soil into buildings primarily through sump holes, dirt floors, floor drains, cinder-block walls, and 
cracks in foundations and concrete floors. When trapped indoors, it can accumulate to significant levels.
Radon’s half-life, 3.8 days, provides sufficient time for it to diffuse into homes, where further decay produces more 
chemically and radiologically active progeny (“radon daughters”). The progeny, which include four isotopes with 
half-lives of less than 30 minutes, are a major source of human exposure to alpha radiation. The alpha radiation 
from radon and its progeny deposited in the lungs may contribute to cellular transformations in the respiratory tract 




Strontium has 16 radioisotopes, six of which are direct fission products of uranium. The most important of these 
isotopes is strontium-90 because of its long radiation half-life of 28 years. Strontium-90 emits a relatively high- 
energy beta particle, giving rise to yttrium-90, which then emits a beta particle of higher energy. In medicine, 
strontium-90 is used to treat cutaneous lesions that are only a few millimeters in depth; in industry, it is used in 
thickness gauges, as a source for static dust elimination by air ionization, a compact heat source, and a 
thermoelectric source in buoys and other devices where a long-lived, independent power source is needed.
Because of the risks posed by strontium-90 from nuclear fallout during atmospheric weapons tests and from the 
possible escape of strontium into the environment during and after reprocessing of used fuel elements, the 
metabolism of strontium-90 has been well studied. After ingestion, about 25% of strontium-90 is absorbed into 
extracellular fluid; after inhalation, about 35% is absorbed into the extracellular fluid. In the body, strontium acts 
much like calcium. About one-half of the amount absorbed is deposited in bone, where the high-energy beta 
particles emitted irradiate both calcified bone and adjacent bone marrow.
The biologic half-life of strontium-90 depends on the route of exposure. It was found to be less than 250 days 
after a single ingestion, about 500 days after inhalation, and 843 days when used as an intravenous tracer dose. 
The average long-term biologic retention is estimated to be 50 years for bone and 36 years for other tissues. 
Strontium-90 is eliminated in the urine and feces. By measuring concentrations of strontium-90 and calcium in 
a 24-hour urine collection, one can estimate the amount of strontium-90 that has accidentally entered the body.
Tritium
Tritium (1 proton and 2 neutrons) is a hydrogen atom that has captured a neutron, resulting in an atomic mass 
of 3. This unstable nucleus emits a beta particle of low energy and has a radiation half-life of 12.3 years. Tritium 
is most familiar in the form of tritiated water (3H20), formed when normal water (H20 ) absorbs neutrons during 
the process of moderating nuclear fission in a reactor. Tritiated water has also been produced in the atmosphere 
as a result of the release of tritium gas from nuclear reactors.
Tritiated water can enter the body by inhalation of water vapor, diffusion through the skin, breaks in the skin, or 
ingestion. The beta particles from tritium are stopped by only 6 millimeters of air or about 5 micrometers of water. 
These beta particles cannot penetrate the outermost layer of skin, and so present no hazard when they originate 
outside the body. However, when they emanate from tritium inside the body, they can produce injury.
Once ingested, tritiated water is completely absorbed and mixes freely with body water. It distributes uniformly 
throughout the body, permeating all tissues. The normal biologic half-life of tritiated water is about 12 days, with 
a small fraction of the radionuclide being excreted at a much slower rate. The complex excretion curve suggests 
that some of the tritium may exchange with organically bound normal water. On the 415th day after a worker 
accidentally ingested tritiated water, the concentration of tritium in urine was still significantly elevated
Uranium-238
Naturally occurring uranium consists of uranium-238 (99.27%), uranium-235 (0.72%) and uranium-234 
(0.0054%). Uranium-235 is extracted or concentrated from natural uranium for use in nuclear weapons or 
nuclear power reactors. The uranium remaining after uranium-235 has been removed is referred to as 
depleted or spent uranium; however, this uranium continues to be a radiation hazard, as well as a chemical 
hazard.
Together the members of the uranium decay series are responsible for significant alpha radioactivity 
contamination in the environment. Initially, uranium-238 decays by emitting high-energy alpha particles. The 
alpha emissions are followed by two beta decays (producing thorium-234 and metastable [short-lived] 
protactinium-234, in succession), which, in turn, are followed by additional alpha emissions from several
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progeny; uranium-234, thorium-230, radium-226, and radon-222. The physical half-life of uranium-238 is 4.5 
billion years; however, its specific activity (radioactivity per given weight), 3.34 microcuries per milligram, 
is low.
The amount of natural uranium that is absorbed by the body depends on its physical state, chemical form, and 
the route of exposure. Based on studies in experimental animals, about 20% of the uranium in blood is retained 
with an effective half-life of 20 days, and about 2.3% is retained with an effective half-life of 5000 days. Most of 
the retained uranium is stored in bone and kidney. Uranium is excreted in urine. Intake of natural uranium in soluble 




Treatment Summary for Internal Contamination, by Selected 
Radioactive Elements
The benefit from therapy recommendations in the Immediate Actions to Consider (column 2) and Drugs to 
Consider (column 3) will be influenced by the route of exposure: ingestion, inhalation, skin absorption, injection, 
or contaminated wounds. The chemical form and solubility of the radionuclide will also change markedly the 
efficacy of the recommended treatment. The table below lists therapeutic procedures or drug therapy that may 
be helpful for the listed elements in favorable circumstances.
































Chelation should be started as soon 
as treatment decision can be made. 
CaEDTAt may be used if CaDTPA 
is not immediately available.
Short-lived isotopes. Use of 
dimercaprol is not indicated except in 
massive exposures.
Use of sodium or magnesium sulfate 
with and after stomach lavage will 
precipitate insoluble barium sulfate.
Massive exposure may warrant use of 
the sodium salt of EDTA , but with 
caution over a 3- to 4-hour period to 
avoid tetany. Furosemide enhances 
urinary excretion.
Same as for Americium.
Low-energy beta rays of carbon-14 
available are not detected by survey 
instruments; collect samples and 
smears for special low-energy beta 
counting in laboratory.
Same as for Americium.
Ion exchange resins should be as 
effective as Prussian blue, but have 
































available for anionic 
forms; DTPA or 

















Antacids are contraindicated. 
Adsorbents, such as charcoal, 
may reduce intestinal tract 
absorption.
Penicillamine may be considered for 
therapeutic trial in large exposures.
Same as for Americium.
None.
Gamma-ray spectroscopy of air or 
swipe samples may identify 
prominent radionuclides (mixed). 
Check also for possible alpha emitters.
Very short half-life. Oral aluminum 
hydroxide gel will reduce absorption 
in the gastrointestinal (Gl) tract.
Short half-life. Penicillamine can be 
considered for therapeutic trial.
No known therapy for colloidal gold.
Success of stable iodine depends on 
early administration.
Materials that reduce Gl absorption 
include egg yolk or adsorbents. Oral 
penicillamine also chelates iron.
CaEDTA may be used if CaDTPA is 
not immediately available.
Dimercaprol and penicillamine are 
less satisfactory alternative drugs.
Dimercaprol may be considered for 
alternative therapy. Gastric lavage 
with egg white solution or 5% sodium 
formaldehyde sulfoxide; if unavailable, 






















Severe overdosage may be treated 
with parathyroid extract (intramuscular) 
in addition to oral phosphates.
DFOA may be used initially if DTPA is 
not available. CaEDTA may also be 
































Consider toxicity of dimercaprol before 
using in cases of low-level exposure. 
Penicillamine is an alternative treatment.
Use aluminum hydroxide antacids first to 
reduce Gl tract absorption. Use oral liquid 
potassium supplements for dilution.
Chelation treatment should be started as 
soon as possible.
Use 10% magnesium sulfate solution 
for gastric lavage and as saline cathartic. 
Oral sulfates reduce intestinal absorp­
tion. No effective therapy after absorption.
Chemical properties are similar to 
potassium, but efficacy of similar 
treatments is unknown.
Chlorthalidone causes enhanced urinary 
excretion. DTPA has variable effectiveness.
EDTA may be used in place of DTPA.
Isotopic dilution (1 liter of 0.9% sodium 
chloride) by intravenous route, followed by 
furosemide or other diuretic agent.
Corticosteroid may be considered, but 
adverse reactions should be balanced 
against probable limited effectiveness.
Potassium perchlorate has been used 
effectively to reduce thyroid dose.
Treatment not effective for thorotrast 
(Th02).
Low-energy beta rays of 3H are not 
detectable by survey instruments; 
requires samples for special low-energy 
beta counting in laboratory.
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Uranium (U) DTPA (None listed) DTPA must be given within 4 hours
to be effective. Sodium bicarbonate 
protects the kidneys from damage.
Yttrium (Y) (None listed) DTPA CaEDTA may be used if CaDTPA is
not immediately available.
Zinc (Zn) Lavage DTPA Zinc sulfate or CaEDTA may be used
as a diluting agent if CaDTPA is not 
immediately available. Penicillamine is 
another alternative.
* DTPA = diethylenetriaminepentaacetic acid 
t  CaEDTA = calcium salt of ethylenediaminetetraacetic acid 
H CaDTPA = calcium diethylenetriaminepentaacetic acid 
§ EDTA = ethylenediaminetetraacetic acid 
** DFOA = deferoxamine or desferrioxamine
t t  Depends on major isotope(s) in mixture, which varies with age of the isotope mixture.
Adapted from: National Council on Radiation Protection and Measurements. Management of persons accidentally contami­
nated with radionuclides. Washington, DC: National Council on Radiation Protection and Measurements, 1980. NCRP Report 
No. 65.
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